NanoLogix is a biotechnology company that focuses on the research, development and commercialization of medical diagnostic products. Its products help in the detection and identification of microorganisms present in infectious and noninfectious human diseases, such as tuberculosis, pneumonia, HIV/AIDS, cancer, cystic fibrosis, anthrax and plague. In addition to medical and homeland security applications, the company s products are utilized in pharmaceutical, veterinary and environmental testing. NanoLogix s technologies are also used in the areas of applied microbiology, microbial physiology, molecular biology, pharmacology, antibiotic sensitivity, stem cell research and bioreactor-based hydrogen generation. Its BNC/BNP technology is utilized for the identification of anthrax. The company operates hydrogen bioreactors at the City of Erie in Pennsylvania and waste water treatment and Welch s Food plants in northeastern Pennsylvania.